You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for Allergan USA, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Allergan USA, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

Docket	⤷ Sign Up	Date Filed	2019-09-13
Court	District Court, D. Delaware	Date Terminated	2023-10-12
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	SUN PHARMACEUTICAL INDUSTRIES LIMITED
Patents	10,188,632; 6,346,532; 7,250,419; 7,741,356; 7,786,158; 8,344,011; 8,425,934; 8,691,860; 9,115,091; 9,364,489; 9,675,587; 9,789,125
Attorneys	Jeremy A. Tigan
Firms	Stamoulis & Weinblatt LLC
Link to Docket	External link to docket

Small Molecule Drugs cited in Allergan USA, Inc. v. MSN Laboratories Private Limited

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Allergan USA, Inc. v. MSN Laboratories Private Limited (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-09-13	1	Complaint	'587 patent"), 9,789,125 ("the '125 patent"), and/or 10,188,632 ("the…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and…860 patent, the '091 patent, the '489 patent, the '587 patent, the '125 patent, and	External link to document
2021-01-11	140	Opinion - Memorandum Opinion	the ʼ489 patent”), 9,789,125 (“the ʼ125 patent”), 9,675,587 (“the ʼ587 patent”), and 10,188,632 (“the ʼ632…terms in U.S. Patent Nos. 8,691,860, 9,115,091, 9,364,489, 9,789,125, 9,675,587, and 10,188,632.. Signed by…Crystalline Form Patents are the ʼ860 patent, the ʼ091 patent, the ʼ489 patent, and the ʼ125 patent. The Abuse-Deterrent… terms in U.S. Patent Nos. 8,691,860 (“the ’860 patent”), 9,115,091 (“the ʼ091 patent”), 9,364,489 (“…Abuse-Deterrent Patents are the ʼ587 patent and the ʼ632 patent. The parties agreed on the constructions	External link to document
2021-02-08	147	Notice of Service	Initial Invalidity Contentions for U.S. Patent No. 9,675,587 filed by Zydus Pharmaceuticals (USA) Inc…2019 12 October 2023 1:19-cv-01727 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-06-02	352	Stipulation-General (See Motion List for Stipulation to Extend Time)	STIPULATION Regarding U.S. Patent Nos. 8,691,860, 9,115,091, 9,364,489, 9,789,125 and 7,741,356 by Allergan Holdings…2019 12 October 2023 1:19-cv-01727 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-06-17	357	Notice of Service	Invalidity and Unenforceability of U.S. Patent Nos. 9,675,587, 10,188,632, 11,007,179, 11,090,291, 111,160,792…2019 12 October 2023 1:19-cv-01727 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.